ASX/AGN (ASX/AGN)

Australian Securities Exchange: ASX/AGN · AUD

A$0.12

+0.01 (+9.5%)· Recorded snapshot

Market cap	14.8M
Revenue (ttm)	5.5M
Net income (ttm)	-1.4M
EPS (ttm)	-A$0.01
Shares out	128.5M
Volume	173,128
Beta	1.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.5M
Net income (ttm): -1.4M
EPS (ttm): -A$0.01
Market cap: 14.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-20.8

P25 -108P50 -50.6P75 1.1

ROIC-15

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/AGN indicators

Market & fundamental data

Available fields

168

Groups with data

Currency

AUD

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-08-28
Enterprise value	AUD 8.4M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2019
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU0000150328
Last earnings date	2026-02-10
Last refreshed	2026-10-30
Market cap	AUD 14.8M
Price	AUD 0.12
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-30
Symbol	asx/AGN
Website	https://argenica.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-9.56%
EV/Sales	1.3x
Industry forward P/E	28.82x
P/B ratio	2.29x
P/S ratio	2.46x
Price / tangible book value	2.29x
Sector forward P/E	34.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-28.75%
Gross margin	100%
Operating margin	-28.75%
Pretax margin	-24.89%
Profit margin	-24.89%
Profitable quarters	1
ROA	-11.23%
ROA (5Y)	-27.55%
ROCE	-26.72%
ROE	-20.78%
ROE (5Y)	-50.69%
ROIC	-15%
SBC / revenue	0.62%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	1
Gross profit growth	70.66%
Gross profit growth (Q)	1,178.81%
Gross profit growth 3Y	46.34%
Gross profit growth 5Y	79.29%
Net income growth quarters	1
Net income growth years	1
Revenue growth	70.66%
Revenue growth (Q)	1,178.81%
Revenue growth (QoQ)	675.09%
Revenue growth 3Y	46.34%
Revenue growth 5Y	79.29%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	AUD -1.6M
EPS	AUD -0.01
Financing cash flow	AUD -2,945
Gross profit	AUD 5.5M
Net cash flow	AUD -4.2M
Net income	AUD -1.4M
Operating cash flow minus SBC	AUD -4.2M
Operating income	AUD -1.6M
Revenue	AUD 5.5M
Stock-based compensation	AUD 33,731

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	34.35
Book value per share	AUD 0.05
Debt / equity	0
Interest coverage	-5,038.55
Long-term assets	AUD 1,000
Long-term liabilities	AUD 0
Net cash (debt)	AUD 6.4M
Net cash / market cap	47.17%
Net cash growth	-39.72%
Net debt / equity	-1.08
Piotroski F-Score	2
Shareholders' equity	AUD 5.9M
Tangible book value	AUD 5.9M
Tangible book value per share	AUD 0.05
Total assets	AUD 6.5M
Total cash	AUD 6.4M
Total debt	AUD 0
Total liabilities	AUD 614,551
WACC	10.18%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.62
Current assets	AUD 6.5M
Current liabilities	AUD 614,551
Current ratio	10.6
Net working capital	AUD -460,846
Quick ratio	10.51
Working capital	AUD 5.9M
Working capital turnover	0.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.73%
Shareholder yield	-0.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.15
1D price change	9.52%
1M price change	-17.86%
1M total return	-17.86%
1W price change	9.52%
1W total return	9.52%
1Y price change	-61.02%
1Y return CAGR	-61.04%
1Y total return	-61.02%
20-day SMA	AUD 0.12
200-day SMA	AUD 0.18
3M price change	-23.33%
3M total return	-23.33%
3Y price change	-65.67%
3Y return CAGR	-29.98%
3Y total return	-65.67%
50-day SMA	AUD 0.16
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.35
52-week high date	2026-01-06
52-week low	AUD 0.09
52-week low date	2026-06-25
5Y price change	-67.61%
5Y return CAGR	-20.19%
5Y total return	-67.61%
6M price change	-34.29%
6M total return	-34.29%
All-time high	AUD 1.02
All-time high date	2022-01-17
All-time low	AUD 0.09
All-time low date	2026-06-25
Average true range (ATR)	AUD 0.01
Average volume	72.7K
Beta (1Y)	1.56
Beta (2Y)	1.2
Beta (5Y)	1.08
Change from 52-week high	-66.67%
Change from 52-week low	32.18%
Change from all-time high	-88.73%
Change from all-time low	32.18%
Change from open	4.55%
Day's gap	4.76%
Dollar volume	AUD 19,910
High price	AUD 0.12
Low price	AUD 0.11
Monthly RSI	35.6
Open price	AUD 0.11
Position in 52-week range	100%
Previous close	AUD 0.11
Price vs 150-day SMA	-22.56%
Price vs 20-day SMA	-7.85%
Price vs 200-day SMA	-34.73%
Price vs 50-day SMA	-26.61%
Relative volume	2.38
RSI	42.19
Sharpe ratio	-0.46
Sharpe ratio (3Y)	0
Sharpe ratio (5Y)	0.13
Sortino ratio	-0.64
Sortino ratio (3Y)	0.07
Sortino ratio (5Y)	0.26
Volume	173.1K
Weekly RSI	38.97
YTD price change	-61.02%
YTD total return	-61.02%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	93.2M
Shares change (QoQ)	-0.09%
Shares change (YoY)	0.73%
Shares held by insiders	20.79%
Shares held by institutions	9.59%
Shares outstanding	128.5M

Deeper analysis on ASX/AGN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/AGN report

Is a complete ASX/AGN research report available?

No complete published report is available for asx/AGN (ASX/AGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/AGN (ASX/AGN)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/AGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/AGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/AGN

Frequently asked questions